Literature DB >> 18563724

Myotonic dystrophy type 1 coexisting with myasthenia gravis and thymoma.

Timothy Feyma1, Gregory T Carter, Michael D Weiss.   

Abstract

Myotonic dystrophy type 1 (DM1) is an autosomal-dominant multisystemic disorder that may rarely be associated with benign and malignant neoplasms. Cases of both thymoma and myasthenia gravis in association with DM1 are extremely rare. A literature review revealed only three prior reports. We present a 51-year-old man with a family history of DM1 and fluctuating diplopia and ptosis, who was found to have acetylcholine receptor-binding antibodies, thymoma, and a clinical presentation compatible with ocular myasthenia gravis as well as positive genetic testing for DM1. Needle electromyographic (EMG) study demonstrated diffuse runs of myotonic discharges in multiple muscles, consistent with the diagnosis of DM1. Single-fiber EMG showed both increased jitter and blocking. Due to somatic instability, which has been shown previously in DM1, the myotonin protein kinase (DMPK) gene appears to act as a tumor suppressor. Therefore, abnormal CTG repeat expansions in the gene could lead to the development of thymoma and myasthenia gravis. (c) 2008 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18563724     DOI: 10.1002/mus.21046

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  5 in total

1.  Imaging of the thymus in myotonic dystrophy type 1.

Authors:  Andrea Mignarri; Francesco Gentili; Francesco Masia; Angelo Genua; Silvia Cenciarelli; Paola Brunori; Maria Antonietta Mazzei; Alessandro Malandrini; Antonio Federico; Francesco Giuseppe Mazzei; Maria Teresa Dotti
Journal:  Neurol Sci       Date:  2017-11-25       Impact factor: 3.307

2.  Impact of biopsychosocial factors on chronic pain in persons with myotonic and facioscapulohumeral muscular dystrophy.

Authors:  Jordi Miró; Katherine A Raichle; Gregory T Carter; Sarah A O'Brien; Richard T Abresch; Craig M McDonald; Mark P Jensen
Journal:  Am J Hosp Palliat Care       Date:  2009-05-04       Impact factor: 2.500

3.  The coexistence of myasthenia gravis and myotonic dystrophy type 2 in a single patient.

Authors:  Ana Nikolic; Vidosava Rakocevic Stojanovic; Stanka Romac; Dusanka Savic; Ivana Basta; Dragana Lavrnic
Journal:  J Clin Neurol       Date:  2013-04-04       Impact factor: 3.077

4.  Thymoma-associated myasthenia gravis coexisting with myotonic dystrophy: a case report.

Authors:  Michiyo Miyawaki; Mika Jikumaru; Kosuke Kamada; Noda Daiki; Miyuki Abe; Kentaro Anami; Hideya Takeuchi; Atsushi Osoegawa; Sintaro Iwao; Etsuro Matsubara; Kenji Sugio
Journal:  Surg Case Rep       Date:  2021-07-08

5.  Loss of MBNL1 induces RNA misprocessing in the thymus and peripheral blood.

Authors:  Łukasz J Sznajder; Marina M Scotti; Jihae Shin; Katarzyna Taylor; Franjo Ivankovic; Curtis A Nutter; Faaiq N Aslam; S H Subramony; Laura P W Ranum; Maurice S Swanson
Journal:  Nat Commun       Date:  2020-04-24       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.